SCHEMBL179213

SCHEMBL179213

N=C(Cl)c1nonc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179219 0.80
SCHEMBL21326547 0.73
SCHEMBL148462 0.73 AKT1 (0.49)
SCHEMBL16706556 0.73 KMT2A (0.39)
SCHEMBL150407 0.73 IDO1 (0.45)
SCHEMBL18043741 0.73 AKT1 (0.49)
SCHEMBL14317086 0.71 KMT2A (0.42)
SCHEMBL20653616 0.71 AKT1 (0.40)
Hydrochloric Acid SCHEMBL19133467 0.71 IDO1 (0.44)
SCHEMBL19934375 0.71 KMT2A (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11207302-B2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2021-12-28 US disclosed
US-11192868-B2 Modulators of indoleamine 2,3-dioxygenase and methods of using the same INCYTE CORPORATION (US) 2021-12-07 US disclosed
US-11053207-B2 Indoleamine-2,3-dioxygenase inhibitor and preparation method therefor SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2021-07-06 US disclosed
US-11046679-B2 Indoleamine 2,3-dioxygenase inhibitor and application NANJING TRANSTHERA BIOSCIENCES CO. LTD. (CN) 2021-06-29 US disclosed
US-20210030722-A1 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase INCYTE CORPORATION 2021-02-04 US disclosed
EP-3398942-B1 SUBSTITUTED OXADIAZOLE CHEMICAL COMPOUND AND COMPOSITION CONTAINING SAID CHEMICAL COMPOUND AND USE THEREOF SHENZHEN TARGETRX INC (CN) 2021-01-27 EP disclosed
US-20200361919-A1 DEUTERATED INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION THEREOF NANJING TRANSTHERA BIOSCIENCES CO. LTD. (CN) 2020-11-19 US disclosed
US-20200181131-A1 INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR AND APPLICATION NANJING TRANSTHERA BIOSCIENCES CO. LTD. (CN) 2020-06-11 US disclosed
US-10653677-B2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase INCYTE HOLDINGS CORPORATION (US) 2020-05-19 US disclosed
US-20190298700-A1 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase INCYTE CORPORATION 2019-10-03 US disclosed
US-20140023663-A1 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3-Dioxygenase INCYTE CORPORATION (US) 2014-01-23 US disclosed
US-20130123246-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2013-05-16 US disclosed
EP-2559690-A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same Incyte Corporation (US) 2013-02-20 EP disclosed
US-8372870-B2 Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer INCYTE CORPORATION (US) 2013-02-12 US disclosed
US-20120058079-A1 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase INCYTE CORPORATION, A DELAWARE CORPORATION 2012-03-08 US disclosed
US-8088803-B2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase INCYTE CORPORATION (US) 2012-01-03 US disclosed
US-20110311479-A1 MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF USING THE SAME INCYTE CORPORATION, A DELAWARE CORPORATION 2011-12-22 US disclosed
US-8034953-B2 Modulators of indoleamine 2,3-dioxygenase and methods of using the same INCYTE CORPORATION (US) 2011-10-11 US disclosed
US-20100015178-A1 1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION 2010-01-21 US disclosed
WO-2010005958-A2 1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE INCYTE CORPORATION (US) 2010-01-14 WO disclosed